Chloe C.West

Associate

London + 44.20.7039.5156

Connect:

Share

Chloe West advises public and private companies and private equity funds on a range of UK and cross-border transactions. Her experience includes acquisitions, disposals, distressed sponsor selection processes, reorganizations, takeovers and schemes, listings, joint ventures, and corporate governance matters. She advises clients across a variety of industry sectors including technology, health care, manufacturing, retail, and funds.

Prior to moving to London in 2023, Chloe was based in Jones Day's Sydney Office, where her highlighted representations included advising: DIC Corporation, a Japanese chemicals group operating globally in more than 60 countries, in connection with its acquisition of Quebec-based PCAS Canada, a company that manufactures and sells polymers used in photoresists for semiconductor photolithography, from PCAS S.A., a French company; a sponsor selection process for a large global Japanese car parts manufacturing and distribution group; Beforepay Group, a pay-on-demand lending company, on its IPO on the ASX (Australian Securities Exchange); Centuria Capital Limited, a leading multisector real estate funds management business, on its acquisition of a 50% interest in Bass Capital Partners, a real estate secured non-banking finance provider for development projects, bridge finance, and residual stock loans throughout Australia; and Pepper Group Limited, a leading diversified global consumer finance business, in connection with its global reorganization.

Experience

  • AURELIUS acquires The Body ShopJones Day advised private equity investor AURELIUS on its acquisition of The Body Shop from Natura & Co S.A.
  • WEG acquires industrial electric motors and generators business from Regal Rexnord CorporationJones Day is advising WEG S.A. in the $400 million acquisition of the industrial electric motors and generators business of Regal Rexnord Corporation.
  • J.M. Huber acquires Biolchim GroupJones Day advised J. M. Huber Corporation in the acquisition of Biolchim Group, a leading producer and distributor of specialty plant nutrition and biostimulants, from private equity firms NB Renaissance and Chequers Capital and the Biolchim Group management team.
  • Beforepay completes A$35 million IPO on ASXJones Day advised Beforepay Group Limited, a leading provider of Pay on Demand services in Australia, in connection with its A$35 million initial public offering on the ASX.
  • rt health and HCF announce merger agreementJones Day advised Railway & Transport Health Fund Ltd (rt health) in its merger with Australia’s third largest private health insurer, the Hospitals Contribution Fund of Australia Limited (HCF).
  • Cardinal Health sells its Cordis business to Hellman & Friedman for approximately $1 billionJones Day advised Cardinal Health in connection with the divestiture of its Cordis business to Hellman & Friedman for approximately $1 billion.
  • Centuria merges with Primewest combining two leading real estate platformsJones Day advised Centuria Capital Group (Centuria), a leading multi-sector real estate funds management business, on its merger-of-equals with the Primewest Group (Primewest), an ASX-listed real estate funds management businesses, with assets across a range of listed, unlisted, and private funds.
  • Koch Equity Development acquires Transaction Network ServicesJones Day advised Koch Equity Development LLC, the acquisition and investment subsidiary of Koch Industries, Inc., in the acquisition of Transaction Network Services, Inc. (TNS) from affiliates of Siris Capital Group, LLC and TNS' other minority equity holders.
  • Pepper Global completes IPO of subsidiary, Pepper Money on ASXJones Day advised Pepper Global on the demerger and initial public offering (IPO) of its subsidiary, Pepper Money Limited, on the ASX.
  • Pepper Global restructures corporate groupJones Day advised Pepper Global, a leading diversified global loan servicer and lender, on a major restructure of its corporate group.
  • Centuria Capital Group acquires 50% interest in Bass CapitalJones Day advised Centuria Capital Group in the acquisition of a 50% interest in Bass Capital Partners Pty Ltd (Bass), a real estate secured non-banking finance provider for development projects, which includes an option to acquire the remaining 50% interest in Bass in five years.
    • View All

    October 2022 Commentary

    M&A Highlights From ASIC's Latest Corporate Finance Update

    September 2021 Commentary

    M&A Highlights From ASIC's September Corporate Finance Update

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.